HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

human MIRN3651 microRNA

RefSeq NR_037424

Also Known As:

MIRN3651 microRNA, human; hsa-mir-3651; miR-3651, human; microRNA-3651, human

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleic Acids: 11752
  - RNA: 69704
    - Untranslated RNA: 2850
      - Small Untranslated RNA: 566
        MicroRNAs: 67298
        human MIRN3651 microRNA: 4
    - Antisense RNA: 1599
      - MicroRNAs: 67298
        human MIRN3651 microRNA: 4
- Antisense Elements (Genetics): 31
  - Antisense RNA: 1599
    - MicroRNAs: 67298
      - human MIRN3651 microRNA: 4

Experts

1.	Bodenhofer, Ulrich: 1 article (03/2022)
2.	Engländer, Immanuela A: 1 article (03/2022)
3.	Fastner, Gerd: 1 article (03/2022)
4.	Grambozov, Brane: 1 article (03/2022)
5.	Karner, Josef: 1 article (03/2022)
6.	Kronberger, Cornelia: 1 article (03/2022)
7.	Ruznic, Elvis: 1 article (03/2022)
8.	Sedlmayer, Felix: 1 article (03/2022)
9.	Sotlar, Karl: 1 article (03/2022)
10.	Stana, Markus: 1 article (03/2022)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 03/01/2022 - "The aim of this study was to elucidate the role of hsa-miR-3651 for predicting of local control (LC) in early breast cancer. " 03/01/2022 - "The current study revealed that hsa-miR-3651 is a predictor of LC in early breast cancer via its putative target protein FRMD3. "
2.	Neoplasms (Cancer) 01/01/2023 - "Furthermore, we also identified significantly enriched novel miRNAs such as hsa-mir-29c-3p, hsa-mir-3651, and hsa-mir-98-3p, which were not previously reported in EBV-related tumors. " 01/01/2023 - "The pan-cancer analysis of miRNA signatures suggested that three miRNAs, hsa-let-7i-3p, hsa-miR-362-3p, and hsa-miR-3651, contributed significantly toward stage prediction across 8 cancers, and each of the 67 miRNAs of the panel was a biomarker of stage prediction in more than one cancer. "
3.	Rectal Neoplasms (Rectal Cancer) 03/10/2016 - "We identified 16 miRNAs for colon and 17 miRNAs for rectal carcinoma that appear to differentiate between carcinoma and normal mucosa; of these, 12 were important for both colon and rectal cancer, hsa-miR-663b, hsa-miR-4539, hsa-miR-17-5p, hsa-miR-20a-5p, hsa-miR-21-5p, hsa-miR-4506, hsa-miR-92a-3p, hsa-miR-93-5p, hsa-miR-145-5p, hsa-miR-3651, hsa-miR-378a-3p, and hsa-miR-378i. "
4.	Hodgkin Disease (Hodgkin's Disease) 01/01/2023 - "We found significantly enriched host miRNAs like hsa-mir-3651, hsa-mir-1248, and hsa-mir-29c-3p in EBV-infected samples from EBV-associated nasopharyngeal carcinoma and Hodgkin's lymphoma, among others. "
5.	Carcinoma (Carcinomatosis) 03/10/2016 - "We identified 16 miRNAs for colon and 17 miRNAs for rectal carcinoma that appear to differentiate between carcinoma and normal mucosa; of these, 12 were important for both colon and rectal cancer, hsa-miR-663b, hsa-miR-4539, hsa-miR-17-5p, hsa-miR-20a-5p, hsa-miR-21-5p, hsa-miR-4506, hsa-miR-92a-3p, hsa-miR-93-5p, hsa-miR-145-5p, hsa-miR-3651, hsa-miR-378a-3p, and hsa-miR-378i. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	MicroRNAs (MicroRNA)
3.	Biomarkers (Surrogate Marker)